For the scenario of "Current obesity treatment with proven efficacy," research data suggests Semaglutide may be more relevant
Cazzola, M., Calzetta, L., Page, C., Jardim, J., Chuchalin, A.G., Rogliani, P., Matera, M.G
36 The ADA also recommends GLP-1 receptor agonists for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease (ASCVD), high ASCVD risk, or CKD
In published rodent studies, BPC-157 has been more extensively investigated for gastrointestinal mucosal protection, tendon-to-bone healing, and organ damage models, whereas TB-500 research has concentrated on dermal wound closure rates, cardiac tissue repair after ischemia, and corneal epithelial recovery
No purchase is available today
L.StanglB